Fredun Pharmaceuticals standalone net profit rises 56.58% in the March 2026 quarter

Sales rise 27.18% to Rs 210.41 crore

Net profit of Fredun Pharmaceuticals rose 56.58% to Rs 11.07 crore in the quarter ended March 2026 as against Rs 7.07 crore during the previous quarter ended March 2025. Sales rose 27.18% to Rs 210.41 crore in the quarter ended March 2026 as against Rs 165.44 crore during the previous quarter ended March 2025.

For the full year,net profit rose 59.59% to Rs 33.21 crore in the year ended March 2026 as against Rs 20.81 crore during the previous year ended March 2025. Sales rose 40.21% to Rs 633.33 crore in the year ended March 2026 as against Rs 451.71 crore during the previous year ended March 2025.

Particulars	Quarter Ended			Year Ended
	Mar. 2026	Mar. 2025	% Var.	Mar. 2026	Mar. 2025	% Var.
Sales	210.41	165.44	27	633.33	451.71	40
OPM %	13.85	10.54	-	14.97	12.20	-
PBDT	14.65	9.29	58	55.50	32.72	70
PBT	11.54	8.04	44	47.59	28.27	68
NP	11.07	7.07	57	33.21	20.81	60

Powered by Capital Market - Live News